We use our own and third-party cookies to optimize your experience on this site, including to maintain user sessions. Without these cookies our site will not function well. If you continue browsing our site we take that to mean that you understand and accept how we use the cookies. If you wish to decline our cookies we will redirect you to Google.
Already have an account? Sign in.

 Remember Me | Forgot Your Password?

FDA Allows Heart Health Claim For Soybean Oil

July 31, 2017: 12:00 AM EST
The FDA has approved a soybean producer’s health claim that soybean oil consumption cuts the risk of heart disease. According to industry analyst Hartman Group, heart health leads the list of health concerns among American consumers. Bunge, the world’s largest producer of soybean oil, said its FDA filing included summaries of clinical studies showing the potential benefits of soybean oil to heart health. Those benefits are based on soybean oil’s positive effect on cholesterol levels and its high concentration of polyunsaturated omega-6 and omega-3 fatty acids versus other oils and fats. The FDA decision means companies can now claim that soybean oil as an ingredient replacing saturated fat may reduce heart disease risk and lower LDL-cholesterol. [Image Credit: © Bunge ]
"FDA Approves Bunge Soybean Oil Heart Health Claim", News release, Bunge, July 31, 2017, © Bunge Limited
Domains
HEALTH & WELLNESS
Body
Food & Nutrition
Heart & Cardiovascular
Other Food & Nutrition
Geographies
Worldwide
North America
United States of America
Categories
Companies, Organizations
Legal, Legislation, Regulation, Policy
Market News
Press Release
Products & Brands
Developed by Yuri Ingultsov Software Lab.